newsfilter
← Latest News
Business Wire·

Takeda Announces First-Quarter FY2025 Results With Significant Late-Stage Pipeline Progression

Revenue Decline of 3.7% at Constant Exchange Rate (CER); 8.4% Decline at Actual Exchange Rates (AER) as VYVANSE® Generic Erosion Impacts Revenue in Line With Company Expectations Core Operating Profit Decline